NTHI insider trading
NasdaqGM HealthcareNEONC TECHNOLOGIES HOLDINGS, INC.: insider trade history from SEC Form 4 filings.
About NEONC TECHNOLOGIES HOLDINGS, INC.
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
Company website: www.neonc.com
NTHI insider activity at a glance
FilingIQ tracks 103 insider transactions for NTHI in filings since Mar 28, 2025. The most recent transaction is dated Sep 15, 2026.
Across the full history, 48 open-market purchases
and 21 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on NTHI insider trades is 56.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest NTHI Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for NTHI?
- FilingIQ tracks 103 Form 4 insider transactions for NTHI (NEONC TECHNOLOGIES HOLDINGS, INC.), covering filings from Mar 28, 2025 onwards. 16 of those are dated within the last 90 days.
- Are NTHI insiders net buyers or net sellers?
- Across the full Form 4 history for NTHI, 48 transactions (47%) were open-market purchases and 21 (20%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does NTHI insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is NTHI in?
- NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $98.23M.
Methodology & sources
Every NTHI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.